Matthew D. Wilkerson

103.4k citations

72 papers · 5.7k indexed · 1 hit paper · h-index 21

Molecular Biology top 2%
Pulmonary and Respiratory Medicine top 1%
Cancer Research top 0.5%
Oncology top 2%
Immunology top 5%

Co-authors: D. Neil Hayes Charles M. Perou Ke Xian A. C. S. Peacock Volker Brendel Joel S. Parker Christopher R. Cabanski Katherine A. Hoadley
Topics: Cancer Genomics and Diagnostics (11 papers)Genomics and Phylogenetic Studies (10 papers)RNA modifications and cancer (8 papers)
Cited by: Cancer Research Pulmonary and Respiratory Medicine Molecular Biology
Journals: Nucleic Acids Research Nature Communications Journal of Clinical Oncology
Partner nations: United States Germany Poland

In The Last Decade

Matthew D. Wilkerson

69 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking

2010 3.5k citations Matthew D. Wilkerson, D. Neil Hayes profile →

Peers

Countries citing papers authored by Matthew D. Wilkerson

Since Specialization

Citations

This map shows the geographic impact of Matthew D. Wilkerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew D. Wilkerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew D. Wilkerson more than expected).

Fields of papers citing papers by Matthew D. Wilkerson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew D. Wilkerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew D. Wilkerson. The network helps show where Matthew D. Wilkerson may publish in the future.

Co-authorship network of co-authors of Matthew D. Wilkerson

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew D. Wilkerson. A scholar is included among the top collaborators of Matthew D. Wilkerson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew D. Wilkerson. Matthew D. Wilkerson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Wild-type RAS signaling is an essential therapeutic target in RAS -mutated cancers 2025 ·Science Signaling ·(unknown),(unknown),(unknown),Erin Sheffels,Hyun Lee,(unknown),(unknown),(unknown),(unknown),Matthew D. Wilkerson,Marielle E. Yohe,Robert L. Kortum	0
2	The influence of microbial colonization on inflammatory versus pro-healing trajectories in combat extremity wounds 2024 ·Scientific Reports ·Seth Schobel,Eric R. Gann,(unknown),Scott F. Grey,Felipe Lisboa,(unknown),Michael Rouse,(unknown),Nicholas A. Be,Xijun Zhang,Clifton L. Dalgard,Matthew D. Wilkerson,Miloš Hauskrecht,Stephen F. Badylak,Rubén Zamora,Yoram Vodovotz,Benjamin K. Potter,Thomas A. Davis,Eric A. Elster	3
3	Uncommon Protein-Coding Variants Associated With Suicide Attempt in a Diverse Sample of U.S. Army Soldiers 2023 ·Biological Psychiatry ·Matthew D. Wilkerson,Daniel Hupalo,Joshua C. Gray,Xijun Zhang,Jiawei Wang,Matthew J. Girgenti,Camille Alba,Gauthaman Sukumar,Nathaniel M. Lott,James A. Naifeh,Pablo A. Aliaga,Ronald C. Kessler,Clesson Turner,Harvey B. Pollard,Clifton L. Dalgard,Robert J. Ursano,Murray B. Stein	2
4	Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatment 2023 ·Gynecologic Oncology ·(unknown),Hong Im Kim,(unknown),Kelly A. Conrads,Brian L. Hood,Tracy Litzi,(unknown),Pang-ning Teng,Clifton L. Dalgard,Xijun Zhang,Matthew D. Wilkerson,Kathleen M. Darcy,Christopher M. Tarney,Neil T. Phippen,Christopher J. Bakkenist,G. Larry Maxwell,Thomas P. Conrads,John I. Risinger,Nicholas W. Bateman	1
5	Transcriptomic Profiling and Pathway Analysis of Mesenchymal Stem Cells Following Low Dose-Rate Radiation Exposure 2023 ·Antioxidants ·(unknown),Matthew D. Wilkerson,Anthony R. Soltis,(unknown),(unknown),(unknown),Lynnette Cary,(unknown),(unknown),Clifton L. Dalgard,Regina M. Day	4
6	Tensin 1 ( TNS1 ) is a modifier gene for low body mass index (BMI) in homozygous [ F508del ]CFTR patients 2021 ·Physiological Reports ·(unknown),Xijun Zhang,Anthony R. Soltis,(unknown),Clifton L. Dalgard,Matthew D. Wilkerson,Douglas Conrad,Harvey B. Pollard	2
7	Integrative Analysis of miRNAs Identifies Clinically Relevant Epithelial and Stromal Subtypes of Head and Neck Squamous Cell Carcinoma 2020 ·Clinical Cancer Research ·(unknown),Vonn Walter,Xiaoying Yin,David Marron,Matthew D. Wilkerson,(unknown),Xiaobei Zhao,Heejoon Jo,D. Neil Hayes,Yoon Ho Ko	9
8	Gene therapy-emulating small molecule treatments in cystic fibrosis airway epithelial cells and patients 2019 ·Respiratory Research ·Qingfeng Yang,Anthony R. Soltis,Gauthaman Sukumar,(unknown),H. Caohuy,(unknown),Clifton L. Dalgard,Matthew D. Wilkerson,Harvey B. Pollard,(unknown)	10
9	Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis 2018 ·Journal of Investigative Dermatology ·Kathleen Conway,Sharon N. Edmiston,Joel S. Parker,Pei Fen Kuan,Yi‐Hsuan Tsai,Pamela A. Groben,Daniel C. Zedek,Glynis Scott,Eloise Parrish,Honglin Hao,(unknown),Jill S. Frank,Craig C. Carson,Matthew D. Wilkerson,Xiaobei Zhao,(unknown),Stergios J. Moschos,David W. Ollila,Nancy E. Thomas	25
10	Chromaffin cell biology: inferences from The Cancer Genome Atlas 2018 ·Cell and Tissue Research ·Lauren Fishbein,Matthew D. Wilkerson	18
11	IGF-1 Receptor Insufficiency Leads to Age-Dependent Attenuation of Osteoblast Differentiation 2015 ·Endocrinology ·Lee‐Chuan C. Yeh,Matthew D. Wilkerson,John C. Lee,Martin L. Adamo	6
12	BRG1/SMARCA4 Inactivation Promotes Non–Small Cell Lung Cancer Aggressiveness by Altering Chromatin Organization 2014 ·Cancer Research ·(unknown),Austin J. Hepperla,Vonn Walter,Shujie Song,Jeremy M. Simon,Joel S. Parker,Matthew D. Wilkerson,Nisarg Desai,Michael B. Major,D. Neil Hayes,Ian J. Davis,Bernard E. Weissman	102
13	SigFuge: single gene clustering of RNA-seq reveals differential isoform usage among cancer samples 2014 ·Nucleic Acids Research ·Patrick K. Kimes,Christopher R. Cabanski,Matthew D. Wilkerson,Ni Zhao,Amy Johnson,Charles M. Perou,Liza Makowski,Christopher A. Maher,Yufeng Liu,J. S. Marron,D. Neil Hayes	14
14	Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma 2013 ·Cancer Research ·Rachel G. Liao,Joonil Jung,Jeremy H. Tchaicha,Matthew D. Wilkerson,Andrey Sivachenko,Ellen M. Beauchamp,Qingsong Liu,Trevor J. Pugh,Chandra Sekhar Pedamallu,D. Neil Hayes,Nathanael S. Gray,Gad Getz,Kwok‐Kin Wong,Robert I. Haddad,Matthew Meyerson,Peter S. Hammerman	134
15	Prediction of Lung Cancer Histological Types by RT-qPCR Gene Expression in FFPE Specimens 2013 ·Journal of Molecular Diagnostics ·Matthew D. Wilkerson,(unknown),D. Neil Hayes,Patrick J. Roberts,Roy R. L. Bastien,Michael E. Mullins,Xiaoying Yin,C. Ryan Miller,Leigh B. Thorne,Katherine B. Geiersbach,Kenneth L. Muldrew,William K. Funkhouser,Cheng Fan,Michele C. Hayward,Steven R Bayer,Charles M. Perou,Philip S. Bernard	16
16	ReQON: a Bioconductor package for recalibrating quality scores from next-generation sequencing data 2012 ·BMC Bioinformatics ·Christopher R. Cabanski,(unknown),Chris Bizon,Matthew D. Wilkerson,Joel S. Parker,Kirk C. Wilhelmsen,Charles M. Perou,J. S. Marron,D. Neil Hayes	13
17	Differential Pathogenesis of Lung Adenocarcinoma Subtypes Involving Sequence Mutations, Copy Number, Chromosomal Instability, and Methylation 2012 ·PLoS ONE ·Matthew D. Wilkerson,Xiaoying Yin,Vonn Walter,(unknown),Christopher R. Cabanski,Michele C. Hayward,C. Ryan Miller,Mark A. Socinski,Alden M. Parsons,Leigh B. Thorne,Benjamin E. Haithcock,Nirmal K. Veeramachaneni,William K. Funkhouser,Scott H. Randell,Philip S. Bernard,Charles M. Perou,D. Neil Hayes	192
18	Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types 2010 ·Clinical Cancer Research ·Matthew D. Wilkerson,Xiaoying Yin,Katherine A. Hoadley,Yufeng Liu,Michele C. Hayward,Christopher R. Cabanski,Kenneth L. Muldrew,C. Ryan Miller,Scott H. Randell,Mark A. Socinski,Alden M. Parsons,William K. Funkhouser,Carrie B. Lee,Patrick J. Roberts,Leigh B. Thorne,Philip S. Bernard,Charles M. Perou,D. Neil Hayes	194
19	yrGATE: a web-based gene-structure annotation tool for the identification and dissemination of eukaryotic genes 2006 ·Genome biology ·Matthew D. Wilkerson,Shannon D. Schlueter,Volker Brendel	17
20	Community-based gene structure annotation 2004 ·Trends in Plant Science ·Shannon D. Schlueter,Matthew D. Wilkerson,Eva Huala,Seung Y. Rhee,Volker Brendel	18

About Matthew D. Wilkerson

Matthew D. Wilkerson is a scholar working on Cancer Research, Behavioral Neuroscience and Molecular Biology, having authored 72 papers that have together received 5.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (11 papers), Genomics and Phylogenetic Studies (10 papers) and RNA modifications and cancer (8 papers). The work is most often cited by research in Cancer Research (1.9k citations), Pulmonary and Respiratory Medicine (2.1k citations) and Molecular Biology (3.3k citations). Matthew D. Wilkerson has collaborated with scholars based in United States, Germany and Poland. Frequent co-authors include D. Neil Hayes, Charles M. Perou, Ke Xian, A. C. S. Peacock, Volker Brendel, Joel S. Parker, Christopher R. Cabanski, Katherine A. Hoadley, Carolyn J. Lawrence and Xiaoying Yin. Their work appears in journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact